Which one of the following Indian institutes was approved by the Drugs Controller General of India for conducting human trials of the Oxford-AstraZeneca Covid-19 vaccine candidate?
Serum Institute of India
The question asks to identify the Indian institute that received approval from the Drugs Controller General of India (DCGI) to conduct human trials for the Oxford-AstraZeneca Covid-19 vaccine candidate.
Conducting human trials is a critical step in vaccine development. It involves testing the safety and effectiveness of a potential vaccine in people before it can be approved for widespread use. In India, this process is overseen by the DCGI.
Let's look at the provided options:
The Serum Institute of India (SII), based in Pune, entered into a partnership with AstraZeneca to manufacture and supply the Oxford University-developed COVID-19 vaccine (later known as Covishield in India). As part of this collaboration, SII was responsible for conducting clinical trials in India to evaluate the vaccine's safety and efficacy on the Indian population.
The Drugs Controller General of India (DCGI), which is the regulatory authority for pharmaceuticals and medical devices in India, granted approval to the Serum Institute of India to conduct the necessary human trials for the Oxford-AstraZeneca vaccine candidate in the country.
Therefore, the Serum Institute of India was the specific Indian institute approved by the DCGI for leading the human trials of the Oxford-AstraZeneca Covid-19 vaccine candidate.
| Institute | Primary Role in Covid-19 Vaccines (Examples) | Involved with Oxford-AstraZeneca Vaccine Trials in India? |
|---|---|---|
| Bharat Biotech | Developed Covaxin (Indigenous vaccine) | No (involved with Covaxin trials) |
| AIIMS | Potential clinical trial sites | Likely trial site, but not lead institute for this vaccine's DCGI approval |
| Serum Institute of India | Manufactured & led trials for Oxford-AstraZeneca vaccine (Covishield) | Yes (Approved by DCGI) |
| National Institute of Epidemiology | Public health research, epidemiology studies | No (not the lead institution for clinical trials) |
Based on the roles of these institutions in India's response to the Covid-19 pandemic and vaccine development efforts, the Serum Institute of India was the entity that partnered with Oxford-AstraZeneca and received DCGI approval to conduct the necessary human trials in India.
| Organization | Key Contribution (Covid-19 Vaccines) |
|---|---|
| Serum Institute of India (SII) | Manufacturing and trials of Oxford-AstraZeneca vaccine (Covishield) |
| Bharat Biotech | Development and trials of Covaxin |
| Drugs Controller General of India (DCGI) | Regulatory approval for vaccines and trials in India |
| Oxford University / AstraZeneca | Developer of the vaccine candidate |
The Drugs Controller General of India (DCGI) is a crucial authority under the Central Drugs Standard Control Organization (CDSCO). Its main function is regulating pharmaceutical and medical devices, including approving licenses for new drugs, clinical trials, and vaccines in India. Any vaccine candidate developed domestically or internationally must undergo clinical trials in India and receive DCGI approval before it can be administered to the public.
The collaboration between international developers like Oxford-AstraZeneca and large Indian manufacturers like Serum Institute of India was vital for scaling up vaccine production and ensuring availability not just in India but globally. This partnership highlights India's significant capacity in vaccine manufacturing.
Which butterfly species was recently named the official butterfly of Jammu and Kashmir?
In how many phases was the general election 2019 conducted in India?
Which one of the following intellectual property rights is protected without making any registration?
Which one of the following units is not a part of All India Radio's Transcription and Programme Exchange Service ?
Which one among the following correctly represents the theme on which the interiors of the new Parliament Building is based?
Lok Sabha | Rajya Sabha | |
(a) | Lotus | Banyan |
(b) | Peacock | Lotus |
(c) | Peacock | Banyan |
(d) | Lotus | Peacock |
The theme of India’s G20 Presidency 'Vasudhaiva Kutumbakam’ or ‘One Earth-One Family-One Future’ is drawn from the
Which one of the following is the first State in India to have 100 percent households with tap water connection?
Consider the following statements :
The Government is promoting the 'Kisan Drone' for
1. Spraying weedicides.
2. Digitisation of land records.
3. Crop assessment.
Which of the statements given above is/are correct?
Under which one of the following rivers has India's first underwater metro rail tunnel been constructed?
A new species of pit-viper was discovered in 2019 and named after the State in which it was found. Identify the State from among the following:
Since the launch of Pradhan Mantri MUDRA Yojana, how much per cent of loans have been given to women entrepreneurs?
As announced in the Budget 2021, to promote seaweed cultivation, Govt. will establish Multipurpose Seaweed Park in ___________ by Indian Government.
Which organization has launched a new technology 'Swastik' to disinfect water using natural oils?
Which one of the following is an important social indicator to measure the extent of equality between men and women in a society, at a given point of time?
As on March 2020, India comprises twenty-eight states and ______ union territories.